Sivakumar Govindan

Dr. Sivakumar Govindan

Research Assistant Professor
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2008 in Tetrahedron Letters
Verified
Journal Article
Closed access
MBManickam Bakthadoss
Manickam Bakthadoss
NSNagappan Sivakumar
Nagappan Sivakumar
Sivakumar GovindanSivakumar Govindan
Sivakumar Govindan
GMGandhi Murugan
Gandhi Murugan

Verified
Journal Article
Open access
PDF file
KWkunchang Wu
kunchang Wu
You Cheng HseuYou Cheng Hseu
You Cheng Hseu
YSYu-Ching Shih
Yu-Ching Shih
Sivakumar GovindanSivakumar Govindan
Sivakumar Govindan
JSJyun-Ting Syu
Jyun-Ting Syu
PCPo-Chen Chu
Po-Chen Chu
Calycosin, a bioactive isoflavonoid isolated from root extracts of Astragalus membranaceus, has been reported to inhibit melanogenesis, the mechanism of which remains undefined. In this study, we interrogated the mechanistic basis by which calycosin inhibits melanin production in two model systems, i.e., B16F10 melanoma cells and zebrafish embryos. Calycosin was effective in protecting B16F10 cells from α-melanocyte-stimulating hormone (α-MSH)-induced melanogenesis and tyrosinase activity. This anti-melanogenic effect was accompanied by decreased expression levels of microphthalmia-associated transcription factor (MITF), a key protein controlling melanin synthesis, and its target genes tyrosinase and tyrosinase-related protein-2 (TRP-2) in calycosin-treated cells. Mechanistically, we obtained the first evidence that calycosin-mediated MITF downregulation was attributable to its ability to block signaling pathways mediated by cAMP response element-binding protein (CREB) and p38 MAP kinase. The protein kinase A (PKA) inhibitor H-89 and p38 inhibitor SB203580 validated the premise that calycosin inhibits melanin synthesis and tyrosinase activity by regulating the PKA/CREB and p38 MAPK signaling pathways. Moreover, the in vivo anti-melanogenic efficacy of calycosin was manifested by its ability to suppress body pigmentation and tyrosinase activity in zebrafish embryos. Together, these data suggested the translational potential of calycosin to be developed as skin-lightening cosmeceuticals.


15 February 2012 in Synthesis
Verified
Journal Article
Closed access
PDF file
MBManickam Bakthadoss
Manickam Bakthadoss
DKDamodharan Kannan
Damodharan Kannan
Sivakumar GovindanSivakumar Govindan
Sivakumar Govindan
The synthesis of novel vicinal coumarin- and oxindole-functionalized dispiropyrrolidines and dispiropyrrolizidines containing three and four contiguous stereogenic centers, respectively, has been accomplished in excellent yields and with high regio- and stereoselectivity. The dispiro compounds are obtained via [3+2]-cycloaddition reactions between (E)-3-benzylidenechroman-2-one and the adduct generated from isatin and N-methylglycine or l-proline.

14 February 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PKPin-Hao Ko
Pin-Hao Ko
YSYa-Ching Shen
Ya-Ching Shen
KMKaliyappan Murugan
Kaliyappan Murugan
CHChiung-Wei Huang
Chiung-Wei Huang
Sivakumar GovindanSivakumar Govindan
Sivakumar Govindan
LLLiang-Chuan Lai
Liang-Chuan Lai
For a newly synthesized compound, identifying its target protein is a slow but pivotal step toward understand its pharmacologic mechanism. In this study, we systemically synthesized novel manzamine derivatives and chose 1-(9′-methyl-3′-carbazole)-3, 4-dihydro-β-carboline (MCDC) as an example to identify its target protein and function. MCDC had potent toxicity against several cancer cells. To identify its target protein, we first used a docking screen to predict macrophage migration inhibitory factor (MIF) as the potential target. Biochemical experiments, including mutation analysis and hydrogen-deuterium exchange assays, validated the binding of MCDC to MIF. Furthermore, MCDC was shown by microarrays to interfere with the cell cycle of breast cancer MCF7 cells. The activated signaling pathways included AKT phosphorylation and S phase-related proteins. Our results showed MIF as a potential direct target of a newly synthesized manzamine derivative, MCDC, and its pharmacologic mechanisms.